A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation

Peretti‐Watel, Patrick; Seror, Valérie; Cortaredona, Sébastien; Launay, Odile; Raude, Jocelyn; Verger, P; Fressard, Lisa; Beck, François; Legleye, Stéphane; l’Haridon, Olivier; Léger, Damien; Ward, Jeremy K.

doi:10.1016/s1473-3099(20)30426-6

Cited by 475 publications

(385 citation statements)

References 10 publications

Supporting

Mentioning

308

Contrasting

Unclassified

Order By: Relevance

“…The degree of vaccination hesitancy found in the present study is broadly consistent with other studies that were published after our study had been completed. Studies conducted during March-April 2020, which was somewhat earlier than the present study (May, 2020), reported findings broadly similar to ours in terms of percentages of people who stated that they would not get vaccinated against SARS-CoV2: Italy (14%) (Barello et al, 2020), France (26%) (COCONEL Group, 2020), and Australia (14%) (Dodd et al, 2020). In a European survey in June, 2020, 24% of respondents stated that they were either unwilling or unsure about getting vaccinated (Neumann-Böhme et al, 2020).…”

Section: Discussionsupporting

confidence: 84%

A Proactive Approach for Managing COVID-19: The Importance of Understanding the Motivational Roots of Vaccination Hesitancy for SARS-CoV2

et al. 2020

View full text Add to dashboard Cite

Importance: Vaccination hesitancy-the reluctance or refusal to be vaccinated-is a leading global health threat (World Health Organization, 2019). It is imperative to identify the prevalence of vaccination hesitancy for SARS-CoV2 in order to understand the scope of the problem and to identify its motivational roots in order to proactively prepare to address the problem when a vaccine eventually becomes available. Objective: To identify (1) the prevalence of vaccination hesitancy for a SARS-CoV2 vaccine, (2) the motivational roots of this hesitancy, and (3) the most promising incentives for improving the likelihood of vaccination uptake when a vaccine does become available. Design, Setting, and Participants: A cross-sectional sample of 3,674 American and Canadian adults assessed during the COVID-19 pandemic in May 2020. Main Outcomes: Measures of vaccination intention (i.e., "If a vaccine for COVID-19 was available, would you get vaccinated?"), attitudes toward vaccines in general and specific to SARS-CoV2 using the Vaccination Attitudes Examination Scale, and incentives for getting vaccinated for those who reported they would not get vaccinated. Results: Many American (25%) and Canadian (20%) respondents said that they would not get vaccinated against SARS-CoV2 if a vaccine was available. Nonadherence rates of this magnitude would make it difficult or impossible to achieve herd immunity. Vaccine rejection was most strongly correlated with mistrust of vaccine benefit, and also correlated with worry about unforeseen future effects, concerns about commercial profiteering from pharmaceutical companies, and preferences for natural immunity. When asked about incentives for getting vaccinated, respondents were most likely to report that evidence for rigorous testing and safety of the vaccine were of greatest importance.

show abstract

Section: Discussionsupporting

confidence: 84%

A Proactive Approach for Managing COVID-19: The Importance of Understanding the Motivational Roots of Vaccination Hesitancy for SARS-CoV2

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Early evidence relating to potential COVID-19 vaccine hesitancy comes from France. In a survey of a representative sample of the French population ten days after the nationwide lockdown was introduced, 26% of respondents said they would not want to receive a future vaccine for COVID-19 (The COCONEL Group, 2020). This was higher among low-income participants (37%) and also prevalent among people aged older than 75 years (22%) who are at high-risk for COVID-19.…”

Section: Introductionmentioning

confidence: 99%

Towards intervention development to increase the uptake of COVID‐19 vaccination among those at high risk: Outlining evidence‐based and theoretically informed future intervention content

Williams

Gallant

Rasmussen

et al. 2020

British J Health Psychol

221

251

View full text Add to dashboard Cite

Objectives. Development of a vaccine against COVID-19 will be key to controlling the pandemic. We need to understand the barriers and facilitators to receiving a future COVID-19 vaccine so that we can provide recommendations for the design of interventions aimed at maximizing public acceptance. Design. Cross-sectional UK survey with older adults and patients with chronic respiratory disease. Methods. During the UK's early April 2020 'lockdown' period, 527 participants (311 older adults, mean age = 70.4 years; 216 chronic respiratory participants, mean age = 43.8 years) completed an online questionnaire assessing willingness to receive a COVID-19 vaccine, perceptions of COVID-19, and intention to receive influenza and pneumococcal vaccinations. A free text response (n = 502) examined barriers and facilitators to uptake. The Behaviour Change Wheel informed the analysis of these responses, which were coded to the Theoretical Domains Framework (TDF). Behaviour change techniques (BCTs) were identified. Results. Eighty-six per cent of respondents want to receive a COVID-19 vaccine. This was positively correlated with the perception that COVID-19 will persist over time, and negatively associated with perceiving the media to have over-exaggerated the risk. The majority of barriers and facilitators were mapped onto the 'beliefs about consequences' TDF domain, with themes relating to personal health, health consequences to others, concerns of vaccine safety, and severity of COVID-19. Conclusions. Willingness to receive a COVID-19 vaccination is currently high among high-risk individuals. Mass media interventions aimed at maximizing vaccine uptake should utilize the BCTs of information about health, emotional, social and environmental consequences, and salience of consequences. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

show abstract

“…Vaccinating a large and culturally diverse global population means that challenges are not only technical but arise also from the attitude of vaccine users. Researchers have indeed warned that vaccine hesitancy and crowd boycott could be the ultimate challenge in the fight against COVID-19 (Peretti-Watel et al 2020 ). Moreover, a global survey on COVID-19 vaccine acceptance showed that in many countries, including those with very active COVID-19 infections, a significant portion of the population refused to vaccinate for COVID-19, including Russia (47%), Poland (45%), Hungary (44%), France (41%), and the USA (33%) (Ipsos 2020 ).…”

Section: Public Trustmentioning

confidence: 99%

“…Moreover, a global survey on COVID-19 vaccine acceptance showed that in many countries, including those with very active COVID-19 infections, a significant portion of the population refused to vaccinate for COVID-19, including Russia (47%), Poland (45%), Hungary (44%), France (41%), and the USA (33%) (Ipsos 2020 ). Such a resistance appears to be due to skepticism on science and a lack of public trust in government authorities (Dror et al 2020 ; Peretti-Watel et al 2020 ). Other resistance factors include conspiracy theories, misinformation and the long-disproven link on vaccine and autism, which are still widely circulating in communities (Stefanelli and Rezza 2014 ; Zuk et al 2019 ).…”

Section: Public Trustmentioning

confidence: 99%

Who is running faster, the virus or the vaccine?

Han

Lichtfouse

2020

Environ Chem Lett

View full text Add to dashboard Cite

show abstract

A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation

Cited by 475 publications

References 10 publications

A Proactive Approach for Managing COVID-19: The Importance of Understanding the Motivational Roots of Vaccination Hesitancy for SARS-CoV2

A Proactive Approach for Managing COVID-19: The Importance of Understanding the Motivational Roots of Vaccination Hesitancy for SARS-CoV2

Towards intervention development to increase the uptake of COVID‐19 vaccination among those at high risk: Outlining evidence‐based and theoretically informed future intervention content

Who is running faster, the virus or the vaccine?

Contact Info

Product

Resources

About